Hexoraletten N

Hexoraletten N contains chlorhexidine dihydrochloride and benzocaine in an oral antiseptic formulation. It is marketed in the European Union as a topical product for oropharyngeal use. The combination provides antimicrobial activity and temporary relief of oral discomfort, typically supplied as a rinse or spray. Exact strength and dosage form are not specified in the available data. It is intended for short‑term application under professional guidance.

Hexoraletten N is indicated for oral mucosal antisepsis and for temporary relief of sore throat or other oral discomfort.

- Reducing bacterial load in the mouth and throat. - Managing mild to moderate oral ulcerations. - Alleviating pain associated with dental procedures. - Supporting oral hygiene after surgery or trauma. - Providing adjunctive care for patients with halitosis related to bacterial overgrowth.

Oral application of Hexoraletten N may be associated with local adverse reactions, most of which are mild and transient.

Common: - Transient burning or stinging sensation. - Mild alteration of taste. - Temporary discoloration of oral tissues. - Mild oral irritation or redness. - Occasional dry mouth. - Brief numbness of the treated area.

Serious: - Allergic contact dermatitis. - Angioedema of the face, lips, or throat. - Severe mucosal ulceration. - Anaphylactic reaction. - Persistent numbness beyond the expected duration. - Systemic toxicity (rare) such as methemoglobinemia.

When using Hexoraletten N, certain precautions should be observed to reduce the risk of adverse events and ensure appropriate use.

- Do not use in patients with known hypersensitivity to chlorhexidine, benzocaine, or related compounds. - Avoid prolonged or excessive application; follow recommended duration of contact. - Keep the product away from eyes and nasal passages. - Use with caution in individuals with a history of methemoglobinemia or severe anemia. - Do not swallow large amounts; rinse thoroughly after use. - Pregnant or breastfeeding individuals should consult a healthcare professional before use.

Hexoraletten N can interact with other substances applied to the oral cavity or absorbed systemically.

Avoid: - Concurrent use of other topical anesthetics containing benzocaine or similar agents, to prevent additive numbness. - Products containing alcohol or strong astringents that may increase mucosal irritation. - Systemic medications that predispose to methemoglobinemia (e.g., dapsone, nitrates) when used with benzocaine.

Use with caution: - Antiseptic mouthwashes containing chlorhexidine may increase cumulative exposure; spacing applications is advisable. - Anticoagulants, as oral irritation could theoretically increase bleeding risk after dental procedures. - Alcohol‑based oral rinses, which may enhance mucosal irritation. - Other local antiseptics, to avoid excessive antimicrobial load. - Dental bleaching agents, which may increase sensitivity when combined.